Hemogenyx Pharmaceuticals (HEMO) Stock Chart & Stock Price History GBX 175.89 -1.36 (-0.77%) As of 06/13/2025 11:30 AM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsHeadlinesBuy This Stock Hemogenyx Pharmaceuticals Stock Price Performance The Hemogenyx Pharmaceuticals (HEMO) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 12,165.69%, with a year-to-date return of -56.25%. In the past month, the stock has decreased 1.46%, reflecting recent market activity. As of the latest close, Hemogenyx Pharmaceuticals traded at GBX 175.89 with a market cap of £6.27 million and volume of 1,612 shares. Five years ago, the stock traded at GBX 5.60, representing a 3,040.89% increase over that period. At the time, it had a market cap of £23.42 million and a volume of 13.96 million shares. Receive HEMO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Hemogenyx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-0.12%1 Month Performance-1.46%3 Month Performance-2.01%Year-To-Date Performance-56.25%1 Year Performance+12,165.69%5 Year Performance+3,040.89% HEMO Stock Chart for Sunday, June, 15, 2025 HEMO Chart by TradingView Hemogenyx Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/13/2025GBX 176.30GBX 175.89-0.23%GBX 176.29GBX 175.501,612 shs£6.27 million06/12/2025GBX 176.34GBX 176.30-0.02%GBX 185GBX 1751,837 shs£6.28 million06/11/2025GBX 176.10GBX 176.34+0.14%GBX 180GBX 176.102,542 shs£6.29 million06/10/2025GBX 175.50GBX 176.10+0.34%GBX 176.10GBX 175.502,502 shs£6.28 million06/09/2025GBX 175GBX 175.50+0.29%GBX 179.50GBX 175.50740 shs£6.26 million06/06/2025GBX 176.35GBX 175-0.77%GBX 184.05GBX 17513,041 shs£6.24 million06/05/2025GBX 179.50GBX 176.35-1.75%GBX 178.78GBX 1754,000 shs£6.29 million06/04/2025GBX 178.90GBX 179.50+0.34%GBX 179.50GBX 176.8066,459 shs£6.40 million06/03/2025GBX 175.60GBX 178.90+1.88%GBX 185GBX 173.50383,125 shs£6.38 million06/02/2025GBX 176.90GBX 175.60-0.73%GBX 179.50GBX 173.5047,025 shs£6.26 million Get the Latest News and Ratings for HEMO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Hemogenyx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 05/30/2025GBX 177.48GBX 176.90-0.32%GBX 179.50GBX 17511,697 shs£6.31 million05/29/2025GBX 177.70GBX 177.48-0.13%GBX 179.50GBX 177.4813,155 shs£6.33 million05/28/2025GBX 176GBX 177.70+0.97%GBX 179.50GBX 175.5053,121 shs£6.33 million05/27/2025GBX 178.30GBX 176-1.29%GBX 179.50GBX 175.9057,489 shs£6.27 million05/26/2025GBX 178.30GBX 178.30GBX 179GBX 17715,508 shs£6.36 million05/23/2025GBX 177.50GBX 178.30+0.45%GBX 179GBX 17715,508 shs£6.36 million05/22/2025GBX 177.50GBX 177.50GBX 178GBX 177.5012,650 shs£6.33 million05/21/2025GBX 178.99GBX 177.50-0.83%GBX 178.99GBX 1751,609 shs£6.33 million05/20/2025GBX 177.53GBX 178.99+0.83%GBX 179.60GBX 178.995,789 shs£6.38 million05/19/2025GBX 179.50GBX 177.53-1.10%GBX 179.78GBX 175.5011,556 shs£6.33 million05/16/2025GBX 178.49GBX 179.50+0.57%GBX 180.50GBX 173.41120,789 shs£6.40 million05/15/2025GBX 180.50GBX 178.49-1.11%GBX 183.73GBX 17731,518 shs£6.36 million05/14/2025GBX 180GBX 180.50+0.28%GBX 180.50GBX 178.58301,459 shs£6.43 million Related Companies Sareum Stock Price Chart Poolbeg Pharma Stock Price Chart Arecor Therapeutics Stock Price Chart OptiBiotix Health Stock Price Chart IXICO Stock Price Chart ImmuPharma Stock Price Chart Synairgen Stock Price Chart Cizzle Biotechnology Stock Price Chart Oxford BioDynamics Stock Price Chart Fusion Antibodies Stock Price Chart Receive HEMO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Hemogenyx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (LON:HEMO) was last updated on 6/15/2025 by MarketBeat.com Staff From Our PartnersAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hemogenyx Pharmaceuticals Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Hemogenyx Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.